Piramal Pharma shares to list on NSE, BSE today after demerger: Check expected listing price

Piramal Pharma Share Listing, Piramal Pharma Listing Price, Piramal Pharma Share Price NSE: Piramal Pharma Limited, which recently demerged from Piramal Enterprises Limited, will list its shares on stock exchanges -- BSE and NSE, today. Earlier in August, Piramal Enterprises Limited at its board meeting had approved the demerger of its pharma business via a composite scheme of the arrangement.

"Trading Members of the exchange are hereby informed that effective from October 19, 2022, the equity shares of Piramal Pharma Limited shall be listed and admitted to dealings on the exchange in the list of T Group of Securities,” according to a notice issued by the BSE.

Piramal Pharma Expected Listing Price

According to Zee Business analyst Nupur, Piramal Pharma share listing price could be around 200-250. 

Zee Business panellist Vijay Chopra, the demerger is good news and that the company will be able to focus on its strength. In the long run, he said that the demerger would be neficial. On Piramal Enterprises share price, he said that the stock has not participated in the market rally and suggested avoiding a stop loss at Rs 800. 

On Piramal Pharma share, Chopra said that he is bullish on the pharma sector and exuded confidence that it will outperform in the coming 6 months.

Piramal Pharma Shares Listing Details 

Piramal Pharma shares would be listed at a fully paid face value of Rs 10 each. The shares will be admitted to dealings on the exchange in the list of T Group of securities.

Piramal Pharma last week had received approval from the Securities and Exchange Board of India (Sebi) to list shares on domestic stock exchanges.

Piramal Enterprises Demerger News

Piramal Pharma, consequent to the approval granted by the National Company Law Tribunal (NCLT), has been demerged from Piramal Enterprises Ltd (PEL) as a part of the simplification of the corporate structure.

Piramal Enterprises Demerger Ratio

According to Piramal Enterprises, the company will issue 4 equity shares of Rs 10 each of Piramal Pharma for every 1 equity share of Rs 2 each to shareholders of Piramal Enterprises Limited.  

Piramal Enterprises Limited will have financial services business, including retail and wholesale lending while Piramal Pharma will have pharma and CDMO business.

Shares of Piramal Enterprises closed around 2.50 per cent higher at Rs 823 on Tuesday, October 16 on NSE. 

Click Here For Latest Updates On Stock Market | Zee Business Live